Patients with following chronic hepatitis C (1)Patients with high blood HCV-RNA level (2)Patients who had no efficacy or had relapse after previous monotherapy of interferon preparation
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Primary osteoporosis
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Refractory Wegener's granulomatosis
Nippon Kayaku Co., Ltd.
2005-09-12
Other
Schizophrenia
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
schizophrenia
Dainippon Sumitomo Pharma Co., Ltd.
2005-09-12
Other
Secondary hyperparathyroidism in hemodialysis patients